Cargando…
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine
Autores principales: | Giuffrida, Gaetano, Condorelli, Annalisa, Di Giorgio, Mary Ann, Markovic, Uros, Sciortino, Roberta, Nicolosi, Daniela, Di Raimondo, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968877/ https://www.ncbi.nlm.nih.gov/pubmed/34382388 http://dx.doi.org/10.3324/haematol.2021.279535 |
Ejemplares similares
-
Immune Thrombocytopenic Purpura Cases Following COVID-19 Vaccination
por: Condorelli, Annalisa, et al.
Publicado: (2021) -
Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Immune thrombocytopenic purpura: case report
Publicado: (2021) -
Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female
por: Jasaraj, Ranjit B, et al.
Publicado: (2021) -
Thrombotic Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Multiple Myeloma: Case Report and Literature Review
por: Dan, Chitramalya, et al.
Publicado: (2023)